Justification for the Use of Aseptic Filling for Sterile Injectable Products

References

1. 1.
   21 CFR 211.113 (b) Control of Microbiological Contamination.
2. 2.↵
   1. Akers J. E.,
   2. Agalloco J. P.

   2012 A more rational approach for sterile product manufacturing. Pharm. Technol. 36 (5), 48–50.

   OpenUrl
3. 3.↵
   1. Allwood M. C.,
   2. Hambleton R.,
   3. Beverley S.

   1975 Pressure changes in bottles during sterilization by autoclaving. J. Pharm. Sci. 64 (2), 333–334.

   OpenUrlPubMed
4. 4.↵
   1. Cundell A. M.,
   2. Fontana A.

   1. Cundell A. M.

   2009 Effects of Water Activity on Microorganisms. In Water Activity Application in the Pharmaceutical Industry; Cundell A. M., Fontana A. , Eds.; Davis Horwood/PDA pp 175–204.
5. 5.
   EMA Note for Guidance on Development Pharmaceutics CPMP/155/96 2000; Annex Decision Trees for the Selection of Sterilization Methods CPMP/QWP/054/098.
6. 6.
   Ph. Eur. Methods of Preparation of Sterile Products.
7. 7.
   FDA Guidance for Industry. Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice, 2004.
8. 8.
   FDA Guideline for the Submission of Documentation for Sterilization Process Validation in Applications for Human and Veterinary Drug Products, 1991.
9. 9.
   FDA Guidance for Industry. Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes, 2010.
10. 10.↵
    1. Friedman R. L.

    2005 Aseptic processing contamination case studies and the pharmaceutical quality systems. PDA J. Pharm. Sci Technol. 59 (2), 118–126.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Denyer S.,
    2. Baird R.

    1. Dewhurst E.,
    2. Hoxey E. V.

    1990 Sterilization Methods. In Guide to Microbiological Control in Pharmaceuticals; Denyer S., Baird R. , Eds.; Ellis Horwood: London pp 182–218.
12. 12.
    ICH Q1A (R2) Stability Testing of New Drug Substances and Products.
13. 13.
    ICH Q8 (R2) Product Development.
14. 14.↵
    1. Jimenez L.

    2007. Microbial diversity in pharmaceutical recalls and environments. PDA J. Pharm. Sci. Technol. 61 (5): 383–399.

    OpenUrlAbstract/FREE Full Text
15. 15.
    1. Mann A.,
    2. Kiefer M.,
    3. Leuenberger H.

    2000 Thermal sterilization of heat-sensitive products using high temperature-short time sterilization. J. Pharm. Sci. 90 (3), 275–287.

    OpenUrl
16. 16.↵
    1. Moser C. L.,
    2. Meyer B. K.

    2011. Comparison of compendial Antimicrobial Effectiveness Tests: a review. AAPS PharmSciTech12 (1), 222–226.

    OpenUrlPubMed
17. 17.↵
    1. Murphy T. D.,
    2. Hokes J.,
    3. Green T. C.,
    4. Cundell A. M.

    1999 Application of response surface methodology to sterilization process development and validation of a water cascade autoclave. PDA J. Pharm. Sci. Technol. 53 (2), 83–94.

    OpenUrlAbstract/FREE Full Text
18. 18.
    1. Nayayama A.,
    2. Yano Y.,
    3. Kobayashi S.,
    4. Ischikawa M.,
    5. Sakai K.

    1996. Comparison of pressure resistances of spores of six Bacillus strains with their heat resistance. Appl. Environ. Microbiol. 62 (10), 3897–3900.

    OpenUrlAbstract/FREE Full Text
19. 19.
    PDA Technical Report #36. Current Practices in the Validation of Aseptic Processing, 2001.
20. 20.
    PDA Technical Report #1 (Revised). Validation of Moist Heat Sterilization Processes: Cycle Design, Development, Qualification and Ongoing Control, 2007.
21. 21.
    PDA Technical Report #30 (Revised 2012). Parametric Release of Pharmaceuticals Terminally Sterilized by Moist Heat.
22. 22.
    1. Sandle T.

    2011 A review of cleanroom microflora: types, trends, and patterns. PDA J. Pharm. Sci. Technol. 65 (4), 392–403.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Gibson M.

    1. Steele G.

    2001 Preformulation as an Aid to Product Design. In Early Drug Development in Pharmaceutical Preformulation and Formulation—A Practical Guide from Candidate Drug Selection to Commercial Dosage Form; Gibson M. , Ed.; CRC Press: Boca Raton, FL; pp 175–238.
24. 24.↵
    1. Sutton S.,
    2. Jimenez L.

    2012. A review of reported recalls involving microbiological control 2004–2011 with emphasis on FDA considerations of objectionable organisms. Amer. Pharm. Rev. 15 (1), 42–57.

    OpenUrl
25. 25.↵
    1. Thiboutot R. P.

    1991 Aseptic processing and terminal sterilization. J. Parent. Sci. Technol. 46 (6), 254–258.
26. 26.
    USP <1222> Terminally Sterilized Pharmaceutical Products—Parametric Release.